DR. OLUKEMI A WALLACE M.D. NPI 1609804350

NPI Information

  • NPI: 1609804350
  • Provider Name: DR. OLUKEMI A WALLACE, M.D.
  • Classification: Specialist - 174400000X
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2220 W MANCHESTER BLVD
    INGLEWOOD, CA
    ZIP 90305
  • Phone: (310) 644-8400

Map and Directions

Get Directions

NPI Details

DR. Olukemi A Wallace, M.D. is a specialist in Inglewood, CA with 41 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Olukemi A Wallace, M.D. NPI is 1609804350. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

2220 W MANCHESTER BLVD
INGLEWOOD, CA
ZIP 90305-514
Phone: (310) 644-8400
Fax: (310) 644-8424

The NPI 1609804350 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Follow-up nursing facility visit per day, typically 35 minutes (HCPCS:99310)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes (HCPCS:99336)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days (HCPCS:99454)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Phosphate level (HCPCS:84100)
  • Uric acid level, blood (HCPCS:84550)
  • Management using the results of remote vital sign monitoring per calendar month, first 20 minutes (HCPCS:99457)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Amylase (enzyme) level (HCPCS:82150)
  • Glutamyltransferase (liver enzyme) level (HCPCS:82977)
  • Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment (HCPCS:99453)
  • Magnesium level (HCPCS:83735)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic (HCPCS:G2012)
  • Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
  • Initial nursing facility visit per day, typically 45 minutes (HCPCS:99306)
  • Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted, for intramuscular use (HCPCS:91300)
  • Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
  • Skin test for tuberculosis (HCPCS:86580)

The enumeration date for this NPI number is 6/30/2006 and was last updated on 8/14/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1174400000XSpecialistA48240CALIFORNIAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.